CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0730

Vitamin D3 20000iu/ml

Filed under Injectable Oils. The bureau holds 129 laboratory returns for this compound from 42 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

42 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 5 10.0 9.9 10.0 21 May 2026 21 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 5 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 4 10.0 9.9 10.0 16 Mar 2026 6 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 4 10.0 9.9 10.0 9 Jan 2026 12 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 4 10.0 9.9 10.0 9 Apr 2026 11 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 10.0 9.9 10.0 11 Dec 2025 3 Jul 2026
SinoPepCASE #VI-2026-0387 A 4 10.0 10.0 10.0 17 Jan 2026 4 Aug 2026
AsymchemCASE #VI-2026-0091 A 4 10.0 9.9 10.0 7 Apr 2026 22 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 3 10.0 9.9 10.0 3 Dec 2025 3 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 3 10.0 9.9 10.0 18 Dec 2025 12 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 10.0 10.0 10.0 21 Apr 2026 7 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 2 10.0 10.0 10.0 26 Mar 2026 3 Aug 2026
WuXi TIDESCASE #VI-2026-0335 A 5 9.9 9.9 10.0 2 Feb 2026 25 Jul 2026
Hubei JianxiangCASE #VI-2026-0048 A 4 9.9 9.9 10.0 6 Jan 2026 4 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 4 9.9 9.9 10.0 11 Jan 2026 2 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 4 9.9 9.9 10.0 21 Apr 2026 9 Aug 2026
BachemCASE #VI-2026-0314 A 3 9.9 9.9 9.9 7 May 2026 17 May 2026
Kerui PeptidesCASE #VI-2026-0626 A 3 9.9 9.9 9.9 21 Mar 2026 26 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 3 9.9 9.9 10.0 21 Jan 2026 21 May 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 9.9 9.9 9.9 17 Jan 2026 10 May 2026
PolyPeptide GroupCASE #VI-2026-0143 A 3 9.9 9.9 9.9 3 May 2026 23 Jun 2026
Sangon BioCASE #VI-2026-0671 A 2 9.9 9.9 10.0 15 Nov 2025 8 May 2026
AmbioPharmCASE #VI-2026-0177 A 2 9.9 9.9 10.0 14 May 2026 6 Aug 2026
Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 X 2 9.2 8.5 9.9 27 Feb 2025 19 Jan 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 5 8.8 8.1 9.6 24 May 2026 24 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 8 8.1 6.8 9.3 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 8.1 6.5 9.5 23 May 2026 23 May 2026
Chimera PeptidesCASE #VI-2026-0260 X 1 8.1 8.1 8.1 9 Jun 2025 9 Jun 2025
Henan Sahe PeptideCASE #VI-2026-0894 X 1 8.1 8.1 8.1 21 May 2025 21 May 2025
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 7 7.7 6.2 8.6 25 May 2026 25 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 2 7.7 6.2 9.2 24 May 2026 24 May 2026
Pure RawzCASE #VI-2026-0767 X 2 7.4 7.0 7.8 11 Jun 2025 26 Jan 2026
Yabang PeptideCASE #VI-2026-0148 X 1 7.2 7.2 7.2 21 May 2025 21 May 2025
AKS ChemCASE #VI-2026-0313 X 1 7.1 7.1 7.1 6 May 2025 6 May 2025
Changan District Sheng Peptide TradingCASE #VI-2026-0341 X 1 7.1 7.1 7.1 11 Jun 2025 11 Jun 2025
Golden EagleCASE #VI-2026-0680 X 1 6.9 6.9 6.9 13 Jun 2025 13 Jun 2025
SRY LabsCASE #VI-2026-0657 X 4 6.8 4.8 8.2 14 Jan 2025 25 May 2026
Limitless Life NootropicsCASE #VI-2026-0980 X 2 6.8 6.7 6.8 2 Jul 2025 19 Jan 2026
Qingdao Hongshengda TradingCASE #VI-2026-0334 X 1 6.6 6.6 6.6 2 Apr 2025 2 Apr 2025
Haikou Mingheng BiotechnologyCASE #VI-2026-0126 X 1 6.3 6.3 6.3 2 Apr 2025 2 Apr 2025
Suaway Lab ResearchCASE #VI-2026-0488 X 3 5.3 2.7 8.1 20 Jun 2025 25 May 2026
HK Fat CatCASE #VI-2026-0376 X 1 0.0 0.0 0.0 6 May 2025 6 May 2025

Open any subject to view the batch-level evidence for Vitamin D3 20000iu/ml alone.